Third Avenue Management, an investment firm based in NYC, highlighted Supernus Pharmaceuticals as a stock pick.
3 reports, 2 independent
Updated Aug 11
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Third Avenue Management, an investment firm based in NYC, highlighted Supernus Pharmaceuticals as a stock pick.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
New York City
most populous city in the United States
-
Supernus Pharmaceuticals (United States)
company in Rockville, United States
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Insider MonkeyHere’s Third Avenue Small-Cap Value Fund’s Update on Supernus Pharmaceuticals (SUPN) Third Avenue Management, an investment management company based in New York City, released its “Third Avenue Small
- Insider MonkeyShould You Consider Adding Champion Homes (SKY) to Your Portfolio? Third Avenue Management, an investment management company based in New York City, released its “Third Avenue Real Estate Value Fund”
- ZacksSupernus (SUPN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates Supernus Pharmaceuticals (SUPN) reported $165.45 million in revenue for the quarter ended June 2025, representing a year-